Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 31Other solid neoplasm 26Thoracic 14Myeloid 12Gastrointestinal 10Breast 7Gynecologic 5Plasma cell 4Lymphoid 4Head & Neck 3Genitourinary 3CNS 3Classical hematology 2Tumor-Agnostic 1Sarcoma 1NET 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1

Interventions

Specimen Handling 36Magnetic Resonance Spectroscopy 31Cyclophosphamide 28Doxorubicin 23Biopsy 22pembrolizumab 21Temozolomide 21X-Rays 17Radiotherapy 17Radiation 16Nivolumab 13fludarabine 12atezolizumab 12Vincristine 12Phantoms, Imaging 12Irinotecan 12Ifosfamide 12Gemcitabine 12cabozantinib 10Bevacizumab 9liposomal doxorubicin 8Surgical Procedures, Operative 8Paclitaxel 8Ipilimumab 8Etoposide 8Immunoglobulin G 7Carboplatin 7palbociclib 6olaparib 6fludarabine phosphate 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Injections × Sarcoma × 90 days × Clear all
NCT07491783 2026-03-24

Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial

Sichuan Enray Pharmaceutical Sciences Company

Phase 2 Not yet recruiting
52 enrolled
Head & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡